Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 20;5(5):809-816.
doi: 10.1016/j.adro.2020.06.001. eCollection 2020 Sep-Oct.

Radiation Therapy for Advanced-Stage Hodgkin Lymphoma

Affiliations
Review

Radiation Therapy for Advanced-Stage Hodgkin Lymphoma

Natalie A Lockney et al. Adv Radiat Oncol. .

Abstract

The backbone of treatment for patients with advanced-stage Hodgkin lymphoma is systemic therapy. The use of radiation therapy as a component of combined-modality treatment in this setting is controversial. In this review, we describe the data in support of and against the use of radiation therapy for stage III and IV Hodgkin lymphoma. Specifically, we review the data for the use of radiation therapy in the consolidation and partial-response settings, including for patients with initial bulky disease. We also discuss the use of radiation therapy in the era of more modern systemic therapies, including checkpoint inhibitors and brentuximab vedotin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic of a treatment algorithm for management of advanced-stage Hodgkin lymphoma in the positron emission tomography era.

References

    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. - PubMed
    1. Hasenclever D., Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on advanced Hodgkin's disease. N Engl J Med. 1998;339:1506–1514. - PubMed
    1. Eichenauer D.A., Aleman B.M.P., Andre M. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv19–iv29. - PubMed
    1. Aleman B.M., Raemaekers J.M., Tirelli U. Involved-field radiotherapy for advanced Hodgkin's lymphoma. N Engl J Med. 2003;348:2396–2406. - PubMed
    1. Johnson P.W., Sydes M.R., Hancock B.W. Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: Survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519) J Clin Oncol. 2010;28:3352–3359. - PubMed

LinkOut - more resources